Above results have demonstrated that decreasing POLRMT expression, using shRNA or CRISPR/Cas9 strategies, induced proliferation inhibition and apoptosis activation in NSCLC cells. The gene discussed is POLRMT; the disease is non-small cell lung carcinoma.